NTP-RISEDRONATE DIN 02358905
Status: Cancelled Pre Market
Holder: NT PHARMA CANADA LTD
Health Canada record
| Active ingredient(s) | RISEDRONATE SODIUM (RISEDRONATE SODIUM MONOHYDRATE) 35 MG |
|---|---|
| Dosage form | Tablet |
| Route | Oral |
| Schedule | PRESCRIPTION |
| Class | Human |
| ATC | M05BA07 RISEDRONIC ACID |
| Original market date | |
| Current status date | 16-Mar-2017 |
| Source | Health Canada DPD |
No Canadian shortage report is currently matched to this DIN.
Other Canadian products containing RISEDRONATE SODIUM (RISEDRONATE SODIUM MONOHYDRATE)
| DIN | Product | Company | Form | Strength | Status |
|---|---|---|---|---|---|
| 02411407 | RISEDRONATE | SIVEM PHARMACEUTICALS ULC | Tablet | RISEDRONATE SODIUM (RISEDRONATE SODIUM MONOHYDRATE) 35 MG | Marketed |
| 02298384 | TEVA-RISEDRONATE | TEVA CANADA LIMITED | Tablet | RISEDRONATE SODIUM (RISEDRONATE SODIUM MONOHYDRATE) 30 MG | Marketed |
| 02298392 | TEVA-RISEDRONATE | TEVA CANADA LIMITED | Tablet | RISEDRONATE SODIUM (RISEDRONATE SODIUM MONOHYDRATE) 35 MG | Marketed |
| 02298376 | TEVA-RISEDRONATE | TEVA CANADA LIMITED | Tablet | RISEDRONATE SODIUM (RISEDRONATE SODIUM MONOHYDRATE) 5 MG | Marketed |
| 02413809 | TEVA-RISEDRONATE | TEVA CANADA LIMITED | Tablet | RISEDRONATE SODIUM (RISEDRONATE SODIUM MONOHYDRATE) 150 MG | Marketed |
| 02358891 | NTP-RISEDRONATE | NT PHARMA CANADA LTD | Tablet | RISEDRONATE SODIUM (RISEDRONATE SODIUM MONOHYDRATE) 30 MG | Cancelled Pre Market |
| 02358883 | NTP-RISEDRONATE | NT PHARMA CANADA LTD | Tablet | RISEDRONATE SODIUM (RISEDRONATE SODIUM MONOHYDRATE) 5 MG | Cancelled Pre Market |
| 02370239 | RISEDRONATE | SANIS HEALTH INC | Tablet | RISEDRONATE SODIUM (RISEDRONATE SODIUM MONOHYDRATE) 5 MG | Cancelled Pre Market |
| 02370247 | RISEDRONATE | SANIS HEALTH INC | Tablet | RISEDRONATE SODIUM (RISEDRONATE SODIUM MONOHYDRATE) 30 MG | Cancelled Pre Market |
| 02326981 | TEVA-RISEDRONATE/CALCIUM | TEVA CANADA LIMITED | Tablet; Kit | RISEDRONATE SODIUM (RISEDRONATE SODIUM MONOHYDRATE) 35 MG; CALCIUM (CALCIUM CARBONATE) 500 MG | Cancelled Pre Market |
Notices of Compliance
| NOC | Date | Submission | Reason |
|---|---|---|---|
| 11962 | 2010-12-30 | Abbreviated New Drug Submission (ANDS) | New manufacturer and product name |